Bile Acids in Hepatobiliary DiseaseT.C. Northfield, H. Ahmed, R. Jazwari, P. Zentler-Munro Springer Science & Business Media, 29. 2. 2000 - Počet stran: 344 This book is the proceedings of the Falk Workshop on `Bile Acids in Hepatobiliary Disease', which took place at the Royal Society of Medicine (RSM) in London, UK, on 29-30 March 1999, and was held in association with the Section of Measurement in Medicine at the RSM. The main interest in bile acid therapy has been recently in cholestatic liver disease. The proceedings of the workshop not only discusses this, but moves on to examine its possible use in alcoholic liver disease, and moves back to re-examine its role in biliary disease. Leading world experts attempt to define its mechanism of action, and the current role of other non-surgical treatments in biliary disease. The physiology and pathogenesis of cholestatic and alcoholic liver disease and cholesterol gallstone disease is also examined. |
Obsah
III | 3 |
IV | 6 |
V | 13 |
VI | 25 |
VII | 30 |
VIII | 39 |
XI | 47 |
XII | 53 |
XXXIII | 174 |
XXXIV | 182 |
XXXVI | 192 |
XXXVIII | 200 |
XXXIX | 213 |
XL | 219 |
XLI | 226 |
XLIV | 236 |
XIII | 57 |
XV | 66 |
XVI | 72 |
XVIII | 87 |
XIX | 91 |
XX | 100 |
XXI | 136 |
XXII | 147 |
XXV | 153 |
XXVIII | 159 |
XXX | 167 |
XLVI | 240 |
XLVII | 248 |
XLVIII | 254 |
XLIX | 263 |
LII | 268 |
LIII | 277 |
LIV | 286 |
LV | 303 |
333 | |
Další vydání - Zobrazit všechny
Bile Acids in Hepatobiliary Disease T.C. Northfield,H. Ahmed,R. Jazwari,P. Zentler-Munro Náhled není k dispozici. - 2000 |
Běžně se vyskytující výrazy a sousloví
acetaldehyde acromegaly activity alcoholic liver disease bile acid therapy bile acid transporter bile duct bile salt biliary lipid bilirubin biochemical bowel canalicular cancer CDCA cells CF patients chenodeoxycholic acid cholecystectomy cholestasis cholesterol cholesterol gallstone cholic acid Clin Invest clinical collagen colonic concentration conjugated bile acids consumption cystic fibrosis decreased dehydrogenase deoxycholic acid dietary dose effect of ursodeoxycholic enterohepatic enzyme ethanol factors faecal Falk Symposium fat absorption fatty acids Figure function gallbladder gallstone gallstone disease gallstone dissolution gallstone formation gallstone recurrence Gastroenterol Gastroenterology gene genetic hepatocyte Hepatol Hepatology Hofmann human ileal impaired increased induced inhibition intake intestinal laparoscopic levels Lieber lipid malabsorption markers membrane metabolism microsomal mixed micelles MTBE normal octreotide oxidation pancreatic pathogenesis Paumgartner G phospholipid placebo plasma primary biliary cirrhosis protein reduced role secretion serum solubilization stones taurine toxicity transit treatment trial UDCA uptake ursodeoxycholic acid vitamin vitro